Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Theranostic Tool to Assess and Enable Spared Spinal Motor Function After SCI

NCT01949285 is registered in ClinicalTrials.gov with NeuroEnabling Technologies, Inc. as lead sponsor.

NCT NCT01949285
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01949285 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Theranostic Tool to Assess and Enable Spared Spinal Motor Function After SCI
Lead sponsor
NeuroEnabling Technologies, Inc.
Phase
Not applicable
Overall status
Completed
Start date
June 30, 2015
Completion date
December 31, 2016
Enrollment
10 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

spinal cord injury